Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,670 | -1,810 | -16,450 | -14,310 | -11,770 |
| Depreciation Amortization | 10 | 6 | 10 | 10 | 8 |
| Other Working Capital | -2,040 | -1,400 | -1,350 | -440 | 1,390 |
| Other Operating Activity | 2,750 | -286 | 460 | 340 | 262 |
| Operating Cash Flow | $-5,950 | $-3,490 | $-17,330 | $-14,400 | $-10,110 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | 0 | -40 | -30 | -20 |
| Other Investing Activity | 0 | 0 | 1,170 | 1,180 | 1,180 |
| Investing Cash Flow | $-10 | $0 | $1,130 | $1,150 | $1,160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 2,988 | N/A | N/A |
| Dividend Paid | 0 | 0 | -740 | -740 | -740 |
| Other Financing Activity | 9,200 | 9,200 | 5,462 | 8,450 | 5,470 |
| Financing Cash Flow | $9,200 | $9,200 | $7,710 | $7,710 | $4,730 |
| Beginning Cash Position | 1,260 | 1,260 | 9,740 | 9,740 | 9,740 |
| End Cash Position | 4,490 | 6,970 | 1,260 | 4,200 | 5,520 |
| Net Cash Flow | $3,230 | $5,710 | $-8,470 | $-5,530 | $-4,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,950 | -3,490 | -17,330 | -14,400 | -10,110 |
| Capital Expenditure | N/A | N/A | -49 | N/A | N/A |
| Free Cash Flow | -5,950 | -3,490 | -17,379 | -14,400 | -10,110 |